ANI PHARMACEUTICALS, INC Net Income (Loss) Available to Common Stockholders, Diluted
ANI PHARMACEUTICALS, INC (ANIP) reported Net Income (Loss) Available to Common Stockholders, Diluted of $24.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $24.71M, a 203.50% increase year-over-year.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $29.49M, a 93.07% increase year-over-year.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $27.49M.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $26.27M.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for fiscal 2025 was $77.18M.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for fiscal 2024 was -$20.15M, a 217.45% decline from fiscal 2023.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for fiscal 2023 was $17.15M.
- ANI PHARMACEUTICALS, INC net income (loss) available to common stockholders, diluted for fiscal 2022 was -$49.52M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24.71M 10-Q · filed 2026-08-07 | $54.20M 10-Q · filed 2026-08-07 | $81.69M derived: sum of 3 quarters · filed 2026-08-07 | $107.97M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $29.49M 10-Q · filed 2026-05-08 | $56.98M derived: sum of 2 quarters · filed 2026-05-08 | $83.25M derived: sum of 3 quarters · filed 2026-05-08 | $91.40M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $27.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $53.76M derived: sum of 2 quarters · filed 2026-02-27 | $61.91M derived: sum of 3 quarters · filed 2026-08-07 | $77.18M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $26.27M 10-Q · filed 2025-11-07 | $34.41M derived: sum of 2 quarters · filed 2026-08-07 | $49.69M 10-Q · filed 2025-11-07 | $39.01M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $8.14M 10-Q · filed 2026-08-07 | $23.42M 10-Q · filed 2026-08-07 | $12.73M derived: sum of 3 quarters · filed 2026-08-07 | -$11.84M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $15.28M 10-Q · filed 2026-05-08 | $4.59M derived: sum of 2 quarters · filed 2026-05-08 | -$19.98M derived: sum of 3 quarters · filed 2026-05-08 | -$22.67M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | -$10.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$35.25M derived: sum of 2 quarters · filed 2026-02-27 | -$37.95M derived: sum of 3 quarters · filed 2026-02-27 | -$20.15M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | -$24.57M 10-Q · filed 2025-11-07 | -$27.27M derived: sum of 2 quarters · filed 2025-11-07 | -$9.46M 10-Q · filed 2025-11-07 | -$8.72M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | -$2.69M 10-Q · filed 2025-08-08 | $15.11M 10-Q · filed 2025-08-08 | $15.86M derived: sum of 3 quarters · filed 2026-02-27 | $25.39M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $17.80M 10-Q · filed 2025-05-09 | $18.55M derived: sum of 2 quarters · filed 2026-02-27 | $28.08M derived: sum of 3 quarters · filed 2026-02-27 | $33.92M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.28M derived: sum of 2 quarters · filed 2026-02-27 | $16.12M derived: sum of 3 quarters · filed 2026-02-27 | $17.15M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $9.53M 10-Q · filed 2024-11-08 | $15.37M derived: sum of 2 quarters · filed 2024-11-08 | $16.41M 10-Q · filed 2024-11-08 | $11.76M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $5.84M 10-Q · filed 2024-08-06 | $5.25M 10-Q · filed 2023-08-09 | $6.87M 10-Q · filed 2024-08-06 | $6.16M 10-Q · filed 2023-08-09 | $2.22M derived: sum of 3 quarters · filed 2025-02-28 | -$6.79M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.03M 10-Q · filed 2024-05-10 | $920.00K 10-Q · filed 2023-05-08 | -$3.62M derived: sum of 2 quarters · filed 2025-02-28 | -$12.62M derived: sum of 3 quarters · filed 2025-02-28 | -$27.95M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$13.66M derived: sum of 2 quarters · filed 2025-02-28 | -$28.99M derived: sum of 3 quarters · filed 2025-02-28 | -$49.52M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$9.01M 10-Q · filed 2023-11-08 | -$24.34M derived: sum of 2 quarters · filed 2023-11-08 | -$44.87M 10-Q · filed 2023-11-08 | -$69.20M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$15.33M 10-Q · filed 2023-08-09 | -$35.87M 10-Q · filed 2023-08-09 | -$60.19M derived: sum of 3 quarters · filed 2024-02-29 | -$64.64M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$20.54M 10-Q · filed 2023-05-08 | -$44.86M derived: sum of 2 quarters · filed 2024-02-29 | -$49.31M derived: sum of 3 quarters · filed 2024-02-29 | -$63.41M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$28.77M derived: sum of 2 quarters · filed 2024-02-29 | -$42.88M derived: sum of 3 quarters · filed 2024-02-29 | -$42.79M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$4.45M 10-Q · filed 2022-11-09 | -$18.55M derived: sum of 2 quarters · filed 2022-11-09 | -$18.47M 10-Q · filed 2022-11-09 | -$22.11M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | -$14.11M 10-Q · filed 2022-08-08 | -$14.02M 10-Q · filed 2022-08-08 | -$17.66M derived: sum of 3 quarters · filed 2023-03-09 | -$17.24M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $81.00K 10-Q · filed 2022-05-10 | -$3.55M derived: sum of 2 quarters · filed 2023-03-09 | -$3.13M derived: sum of 3 quarters · filed 2023-03-09 | -$15.47M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | -$3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$3.21M derived: sum of 2 quarters · filed 2023-03-09 | -$15.55M derived: sum of 3 quarters · filed 2023-03-09 | -$22.55M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $421.00K 10-Q · filed 2021-11-01 | -$11.91M derived: sum of 2 quarters · filed 2021-11-01 | -$18.91M 10-Q · filed 2021-11-01 | -$23.68M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-06-30 | -$12.34M 10-Q · filed 2021-08-06 | -$19.35M 10-Q · filed 2021-08-06 | -$24.10M derived: sum of 3 quarters · filed 2022-03-15 | -$20.27M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-03-31 | -$7.01M 10-Q · filed 2021-05-07 | -$11.77M derived: sum of 2 quarters · filed 2022-03-15 | -$7.93M derived: sum of 3 quarters · filed 2022-03-15 | -$1.46M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2019-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$924.00K derived: sum of 2 quarters · filed 2022-03-15 | $5.56M derived: sum of 3 quarters · filed 2022-03-15 | $6.00M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | $3.83M 10-Q · filed 2020-11-05 | $10.31M derived: sum of 2 quarters · filed 2020-11-05 | $10.75M 10-Q · filed 2020-11-05 | $16.13M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $6.48M 10-Q · filed 2020-08-06 | $6.92M 10-Q · filed 2019-08-07 | $12.30M derived: sum of 3 quarters · filed 2021-03-11 | $17.28M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-03-31 | $440.00K 10-Q · filed 2020-05-07 | $5.82M derived: sum of 2 quarters · filed 2021-03-11 | $10.80M derived: sum of 3 quarters · filed 2021-03-11 | $13.55M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | $5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $10.36M derived: sum of 2 quarters · filed 2021-03-11 | $13.11M derived: sum of 3 quarters · filed 2021-03-11 | $15.34M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $4.99M 10-Q · filed 2019-11-06 | $7.74M derived: sum of 2 quarters · filed 2019-11-06 | $9.96M 10-Q · filed 2019-11-06 | $407.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $2.75M 10-Q · filed 2019-08-07 | $4.98M 10-Q · filed 2019-08-07 | -$4.58M derived: sum of 3 quarters · filed 2020-02-27 | $106.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $2.24M 10-Q · filed 2019-05-09 | -$7.33M derived: sum of 2 quarters · filed 2020-02-27 | -$2.64M derived: sum of 3 quarters · filed 2020-02-27 | $18.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | -$9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$4.88M derived: sum of 2 quarters · filed 2020-02-27 | -$2.22M derived: sum of 3 quarters · filed 2020-02-27 | -$1.08M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $4.68M 10-Q · filed 2018-11-06 | $7.35M derived: sum of 2 quarters · filed 2018-11-06 | $8.49M 10-Q · filed 2018-11-06 | $7.42M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $2.66M 10-Q · filed 2017-08-03 | $3.81M 10-Q · filed 2018-08-07 | $2.73M derived: sum of 3 quarters · filed 2019-02-27 | $5.26M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $1.14M 10-Q · filed 2018-05-08 | $74.00K derived: sum of 2 quarters · filed 2019-02-27 | $2.60M derived: sum of 3 quarters · filed 2019-02-27 | $3.72M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.46M derived: sum of 2 quarters · filed 2019-02-27 | $2.58M derived: sum of 3 quarters · filed 2019-02-27 | $3.91M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $2.53M 10-Q · filed 2017-11-02 | $3.64M derived: sum of 2 quarters · filed 2017-11-02 | $4.98M 10-Q · filed 2017-11-02 | $7.86M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $1.12M 10-Q · filed 2017-08-03 | $2.45M 10-Q · filed 2017-08-03 | $5.33M derived: sum of 3 quarters · filed 2018-02-27 | $9.86M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $1.34M 10-Q · filed 2017-05-04 | $4.21M derived: sum of 2 quarters · filed 2018-02-27 | $8.74M derived: sum of 3 quarters · filed 2018-02-27 | $12.29M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $7.40M derived: sum of 2 quarters · filed 2018-02-27 | $10.95M derived: sum of 3 quarters · filed 2018-02-27 | $15.29M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $4.53M 10-Q · filed 2016-11-03 | $8.08M derived: sum of 2 quarters · filed 2016-11-03 | $12.42M 10-Q · filed 2016-11-03 | $33.37M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-06-30 | $3.55M 10-Q · filed 2016-08-04 | -$3.55M 10-Q · filed 2015-08-04 | $7.89M 10-Q · filed 2016-08-04 | -$7.89M 10-Q · filed 2015-08-04 | $28.84M derived: sum of 3 quarters · filed 2017-03-02 | $35.50M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $4.35M 10-Q · filed 2016-05-05 | $25.29M derived: sum of 2 quarters · filed 2017-03-02 | $31.95M derived: sum of 3 quarters · filed 2017-03-02 | $34.31M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $20.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $27.61M derived: sum of 2 quarters · filed 2017-03-02 | $29.97M derived: sum of 3 quarters · filed 2017-03-02 | $28.59M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $6.66M 10-Q · filed 2015-11-03 | $9.03M derived: sum of 2 quarters · filed 2015-11-03 | $7.65M 10-Q · filed 2015-11-03 | $15.74M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $2.36M 10-Q · filed 2015-08-04 | -$2.36M 10-Q · filed 2014-08-07 | -$985.00K 10-Q · filed 2015-08-04 | $985.00K 10-Q · filed 2014-08-07 | $9.07M derived: sum of 3 quarters · filed 2016-02-23 | $10.10M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $3.33M 10-Q · filed 2015-05-05 | $6.71M derived: sum of 2 quarters · filed 2016-02-23 | $7.73M derived: sum of 3 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $4.41M derived: sum of 2 quarters · filed 2016-02-23 | -$4.87M 10-K · filed 2016-02-23 | |||
| 2013-09-30 | $1.02M 10-Q · filed 2014-11-10 | -$8.26M 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |